CYP2D6 ALLELE DISTRIBUTION IN MACEDONIANS,
ALBANIANS AND ROMANIES IN THE
REPUBLIC OF MACEDONIA
Kuzmanovska M, Dimishkovska M, Maleva Kostovska I, Noveski P,
Sukarova Stefanovska E, Plaseska-Karanfilska D*
*Corresponding Author: Dijana Plaseska-Karanfilska, M.D., Ph.D., Research Centre for Genetic Engineering
and Biotechnology “Georgi D. Efremov,” Macedonian Academy of Sciences and Arts, Krste Misirkov 2, 1000
Skopje, Republic of Macedonia. Tel: +389-2-3235-410. Fax: +389-2-3115-434. E-mail: dijana@manu.edu.mk
page: 49
|
|
REFERENCES
1. Gardiner SJ, Begg EJ. Pharmacogenetics, drugmetabolizing
enzymes, and clinical practice.
Pharmacol Rev. 2006; 58(3): 521-590.
2. Nelson DR, Zeldin DC, Hoffman SM, Maltais
LJ, Wain HM, Nebert DW. Comparison of cytochrome
P450 (CYP) genes from the mouse
and human genomes, including nomenclature
recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics.
2004; 14(1): 1-18.
3. Kimura S, Umeno M, Skoda RC, Meyer UA,
Gonazalez FJ. The human debrisoquine 4-hydrolase
(CYP2D) locus: Sequence and identification
of the polymorphic CYP2D6 gene, a related
gene, and a pseudogene. Am J Hum Genet. 1989;
45(6): 889-904.
4. The Human Cytochrome P450 (CYP) Allele Nomenclature
committee. (http://www.cypalleles.
ki.se/ cyp2d6.htm)
5. Steen VM, Andreassen OA, Daly AK, Tefre T,
Borresen A-L, Idle JR, et al. Detection of the
poor metab-olizer-associated CYP2D6(D) gene
deletion allele by long-PCR technology. Pharmacogenetics.
1995; 5(4): 215-223.
6. Johansson I, Lundqvist E, Bertilsson L, Dahl
ML, Sjoqvist F, Ingelman-Sundberg M. Inherited
amplification of an active gene in the cytochrome
P450 CYP2D locus as a cause of ultrarapid metabolism
of debrisoquine. Proc Natl Acad Sci
USA. 1993; 90(24): 11825-11829.
7. The Pharmacogenomics Knowledge Base (PharmGKB)
(https://www.pharmgkb.org/page/cpic).
8. Evans WE, Relling MV. Moving towards individualized
medicine with pharmacogenomics.
Nature. 2004; 429(6990): 464-468.
9. Ma MK, Woo MH, McLeod HL. Genetic basis
of drug metabolism. Am J Health Syst Pharm.
2002; 59(21): 2061-2069.
10. Ingelman-Sundberg M, Oscarson M, McLellan
RA. Polymorphic human cytochrome P450 enzymes:
An opportunity for individualized drug
treatment. Trends Pharmacol Sci. 1999; 20(8):
342-349.
11. Meyer UA. Pharmacogenetics – five decades of
therapeutic lessons from genetic diversity. Nat
Rev Genet. 2004; 5(9): 669-676.
12. Bradford LD. CYP2D6 allele frequency in European
Caucasians, Asians, Africans and their
descendants. Pharmacogenomics. 2002; 3(2):
229-243.
13. Tateishi T, Chida M, Ariyoshi N, Mizorogi Y,
Kamataki T, Kobayashi S. Analysis of the CYP2D6
gene in relation to dextromethorphan Odemethylation
capacity in a Japanese population.
Clin Pharmacol Ther. 1999; 65(5): 570-575.
14. Gaedigk A, Gotschall RR, Forbes NS, Simon
SD, Kearns GL, Leeder JS. Optimization of cytochrome
P4502D6 (CYP2D6) phenotype assignment
using a genotyping algorithm based on
allele frequency data. Phar-macogenetics. 1999;
9(6): 669-682.
15. Sistonen J, Sajantila A, Lao O, Corander J, Barbujani
G, Fuselli S. CYP2D6 worldwide genetic
variation shows high frequency of altered activity
variants and no continental structure. Pharmacogenet
Genomics. 2007; 17(2): 93-101.
16. Ingelman-Sundberg M. Genetic polymorphisms
of cytochrome P450 2D6 (CYP2D6): Clinical
consequences, evolutionary aspects and functional
diversity. Pharmacogenomics J. 2004;
5(1): 6-13.
17. Soderback E, Zackrisson AL, Lindblom B, Alderborn
A. Determination of CYP2D6 gene copy
number by pyrosequencing. Clin Chem. 2005;
51(3): 522-531.
18. Lundqvist E, Johansson I, Ingelman-Sundberg
M. Genetic mechanisms for duplication and multiduplication
of the human CYP2D6 gene and
methods for detection of duplicated CYP2D6
genes. Gene. 1999; 226(2): 327-338
19. Lindpaintner K. Pharmacogenetics and the future
of medical practice. Br J Clin Pharmacol. 2002;
54(2): 221-230.
20. Kirchheiner J, Nickchen K, Bauer M, Wong ML,
Licinio J, Roots I, et al. Pharmacogenetics of
antidepressants and antipsychotics: The contribution
of allelic variations to the phenotype of
drug response (Review). Mol Psychiatry. 2004;
9(5): 442-473.
21. Sistonen J, Fuselli S, Levo A, Sajantila A. CYP
2D6 genotyping by a multiplex primer extension
reaction. Clin Chem. 2005; 51(7): 1291-1295.
22. Goddard KA, Hopkins PJ, Hall JM, Witte JS.
Linkage disequilibrium and allele-frequency
distributions for 114 single-nucleotide polymorphisms
in five populations. Am J Hum Genet.
2000; 66(1): 216-234.
23. Rebsamen MC, Desmeules J, Daali Y, Chiappe
A, Diemand A, Rey C, et al. The AmpliChip
CYP450 test: Cytochrome P450 2D6 genotype
assessment and phenotype prediction. Pharmacogenomics
J. 2009; 9(1): 34-41.
24. Umamaheswaran G, Dhakchinamoorthi K,
Chan-drasekaran A. Distribution of genetic polymorphisms
of genes encoding drug metabolizing
enzymes & drug transporters – a review with
Indian perspective. Indian J Med Res. 2014;
139(1): 27-65.
25. Al-Dosari M, Al-Jenoobi F, Alkharfy K, Alghamdi
A, Bagulb K, Parvez M, et al. High prevalence
of CYP 2D6*41 (G2988A) allele in Saudi Arabians.
Environ Toxicol Pharmacol. 2013; 36(3):
1063-1067. doi: 10.1016/j. etap.2013.09.008.
26. Qumsieh RY, Ali BR, Abdulrazzaq YM, Osman
O, Akawi NA, Bastaki SMA. Identification of
new alleles and the determination of alleles and
genotypes frequencies at the CYP2D6 gene in
Emiratis. PLoS ONE. 2011; 6(12): e28943. doi:
10.1371/journal.pone.0028943.
27. Kapedanovska Nestorovska A, Jakovski K, Naumovska
Z, Hiljadnikova Bajro M, Sterjev Z, Eftimov
A, et al. Distribution of the most common
genetic variants associated with a variable drug
response in the population of the Republic of
Macedonia. Balkan J Med Genet. 2014; 17(2):
5-14. doi: 10.2478/bjmg-2014-0069.
28. Chou WH1, Yan FX, de Leon J, Barnhill J, Rogers
T, Cronin M, et al. Extension of a pilot study:
Impact from the cytochrome P450 2D6 polymorphism
on outcome and costs associated with
severe mental illness. J Clin Psychopharmacol.
2000; 20(2): 246-251.
29. Bozina N, Granić P, Lalić Z, Tramisak I, Lovrić
M, Stavljenić-Rukavina A. Genetic polymorphisms
of cytochromes P450: CYP2C9, CYP2C19,
and CYP2D6 in Croatian population.
Croat Med J. 2003; 44(4): 425-428.
30. Arvanitidis K, Ragia G, Iordanidou M, Kyriaki
S, Xanthi A, Tavridou A, et al. Genetic polymorphisms
of drug-metabolizing enzymes CYP2D6,
CYP2C9, CYP2C19 and CYP3A5 in the Greek
population. Fundam Clin Pharmacol. 2007;
21(4): 419-426.
31. Buzková H, Pechandová K, Slanar O, Perlik F.
Frequency of single nucleotide polymorphisms
of CYP-2D6 in the Czech population. Cell Biochem
Funct. 2008; 26(1): 76-81.
32. Sachse C, Brockmoller J, Bauer S, Roots I.
Cytochrome P450 2D6 variants in a Caucasian
population: Allele frequencies and phenotypic
consequences. Am J Hum Genet. 1997; 60(2):
284-295.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
